A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Ebola virus is an infectious agent and one of the viruses that can cause haemorraghic fever, a severe infectious disease characterized by high fever and bleeding, in humans and some monkeys.

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

This was the first time many had ever heard of the virus, but since it was first identified in 1976, there have actually been more than 20 serious Ebola incidents. Thankfully, none of them had the ...

The ministry of Health announced Sudan Ebola Virus Disease outbreak on January 30, 2025, marking the country’s eighth Ebola ...

This was the first time many had ever heard of the virus, but since it was first identified in 1976, there have actually been more than 20 serious Ebola incidents. Thankfully, none of them had the ...

Harty has been working on Ebola for more than two decades. In trying to better understand virus-host interactions to identify better treatments, he has focused on VP40, the viral matrix protein ...

Cameron McWhirter covers national affairs for The Wall Street Journal from Atlanta. Before joining the Journal, he reported ...

The Ebola virus disease outbreak now ravaging parts of West Africa is the largest on record. In fact, West Africa has seen more cases of the disease in 2014 than have been seen in all other ...

The US government says the donation is an addition to its ongoing contributions to Uganda’s Ebola response, such as support ...